Zoetis Receives Health Canada Approval for Portela™(relfovetmab injection) to Alleviate Pain Associated with Osteoarthritis in Cats

Core Insights - Zoetis Inc. has received approval from Health Canada for Portela™ (relfovetmab injection), aimed at alleviating pain associated with osteoarthritis (OA) in cats [1] - Portela is designed to provide three months of OA pain relief with a single injection, targeting anti-nerve growth factor (NGF), a key mediator of OA pain and inflammation [1] - A nine-month field trial conducted in Europe demonstrated Portela's effectiveness in alleviating OA pain and confirmed its safety [1]